Long term safety of statins should be monitored

BMJ. 2006 Sep 23;333(7569):656. doi: 10.1136/bmj.333.7569.656.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Long-Term Care
  • Product Surveillance, Postmarketing

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors